GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IR-Med IRME · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

IR-Med — daily IRME Delayed
Market value
$226,611
Last close × shares
Volume
594
Shares, 30 Oct 2026

About IR-Med

Its shares trade under the ticker IRME. It has been listed since 18 July 2001.

IR-Med, Inc. is engaged in the designing and developing devices utilizing spectrographic usability medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies. The company is headquartered in New York City, New York. The company went IPO on 2001-07-18. The firm develops non-invasive devices for various medical indications, by detecting and measuring various biomarkers and molecules in the blood and in human tissue in real-time. The Company’s devices allow healthcare professionals to detect and measure different molecules in the blood and in human tissue in real-time without any invasive procedures. Its initial product candidates are in various stages of development. The company is focused on two principal medical devices: PressureSafe and Nobiotics. PressureSafe is a handheld optical monitoring device that is being developed to support the early detection of pressure injuries (PI) to the skin and underlying tissue, primarily caused by prolonged pressure associated with bed confinement. Nobiotics is an otoscope, which is designed to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media) is of a bacterial origin.

Figures and description from our data supplier, not checked against the company's own report.

More about IR-Med →

Latest on IR-Med

Our reporting

We have not reported on IR-Med yet.

Next results

2 Dec 2026

Due on 2 Dec 2026. Analysts expect earnings of -0.02 a share.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is IR-Med's ticker?

IR-Med trades as IRME on its US listing, under ISIN US46265R1032.

What was IR-Med's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

When does IR-Med next report results?

Results are expected on 2 Dec 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.